Crinetics Pharmaceuticals, Inc(NASDAQ:CRNX) 
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin recept...
Website: http://www.crinetics.com
Founded: 2008
Full Time Employees: 68
Founder: R. Scott Struthers, Stephen F. Betz, Ana Kusnetzow, and Yun-Fei Zhu
CEO: R. Scott Struthers
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 28.15
H 28.54
L 26.48
C 26.89
V 1,211,667
10EMA 26.89
20EMA 26.89
60EMA 26.89
120EMA 26.89
250EMA 26.89